Breast cancer: Fosnetupitant safe in patients receiving AC/EC chemotherapyFebruary 22, 2022Breast Cancer
ER+ BC: Reduced recurrence with aromatase inhibitors vs. tamoxifen in premenopausal womenFebruary 22, 2022Breast Cancer
Breast cancer: PTV of 9 susceptibility genes could guide gene panel testing and risk predictionFebruary 22, 2022Breast Cancer
Adding capecitabine to adjuvant chemotherapy improves RFS in non-BRCA1-like early TNBCFebruary 22, 2022Breast Cancer
TNBC: Adding carboplatin to neoadjuvant chemotherapy provides long-term EFS benefitFebruary 22, 2022Breast Cancer
Pyrotinib+capecitabine shows promise for HER2+ metastatic breast cancer and brain metastasesFebruary 22, 2022Breast Cancer
Oncology PracticeBreast cancer trials enrolling now: Could your patient benefit?February 18, 2022Breast Cancer
Oncology PracticeExperimental breast cancer immunotherapy treatment passes important hurdle in pilot studyFebruary 17, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeIncrease in late-stage cancer diagnoses after pandemicFebruary 16, 2022Metastatic Breast CancerBreast CancerGastrointestinal CancerPreventive CareGastroenterologyGI Oncology
Oncology PracticeBreast cancer now leading cause of cancer death in Black womenFebruary 10, 2022Breast CancerDiversity in Medicine
Oncology PracticeCost not a factor in radiotherapy type for breast cancer patientsFebruary 10, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeSome U.S. women not getting ET for curable breast cancerFebruary 1, 2022Breast Cancer
Oncology PracticeNew combo therapy for breast implant–associated lymphomaJanuary 25, 2022Breast CancerMetastatic Breast Cancer
Oncology PracticeMedicare NCDs hinder access to cancer biomarker testing for minoritiesJanuary 25, 2022Breast CancerLung CancerMetastatic Breast CancerGastrointestinal CancerMelanoma
